Mustang Bio Selected as a Bronze Winner in Eighteenth Annual Team Massachusetts Economic Impact Awards

3 years ago

WORCESTER, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on…

Satsuma Pharmaceuticals to Present at the Virtual 11th Annual SVB Leerink Global Healthcare Conference

3 years ago

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing…

Intrommune Reports Positive Update from Ongoing Phase 1 Study in Peanut Allergy

3 years ago

INT301 Met Safety Goals Across Four Dose Levels in Cohort 1 Patient Treatment Now Ongoing in Fully Enrolled Cohort 2…

HealthEC Receives 2022 Best in KLAS Award for Population Health Management

3 years ago

Population health management industry leader recognized receives top honor with high marks in customer satisfaction and loyalty in the annual…

Outlook Therapeutics Expands Commercial Team with Appointment of Senior Vice President of Commercial Operations

3 years ago

Joel Prieve brings nearly 20 years of commercial operations expertise and proven track record in sales and account managementISELIN, N.J.,…

Vistin Pharma ASA: Invitation to Q4 2021 conference call

3 years ago

Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results on Thursday 17th of February 2022.…

Route 92 Medical® Announces First Patient Enrollment in the SUMMIT MAX Pivotal Clinical Trial for the Monopoint® Reperfusion System

3 years ago

SAN MATEO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a private medical technology company dedicated to…

Eyenovia Concludes Type A Meeting with FDA Related to MydCombi™ NDA Resubmission

3 years ago

No additional clinical work required; NDA resubmission anticipated in Q3 2022NEW YORK, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc.…

Healx and Ovid Therapeutics to Enter Strategic Partnership

3 years ago

– Ovid to License Gaboxadol to Healx – – Healx to Explore Gaboxadol in Combination Therapies for Fragile X, Other…

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

3 years ago

Creators of the world’s first FDA-cleared portable MRI scales executive team for its next phase of development Dr. Chip Truwit,…